SPAC bust: ARCH, Deer­field and Sec­tion 32 can­cel their $200M life sci­ences bet

A life sci­ences SPAC backed by in­dus­try in­vestors Sec­tion 32, Deer­field Man­age­ment and ARCH Ven­ture Part­ners is clos­ing shop well af­ter the blank-check fad end­ed and eight months af­ter an­oth­er ARCH shell com­pa­ny quit.

DA32 Life Sci­ence Tech Ac­qui­si­tion Corp., which trades as $DALS, will dis­solve and re­deem its out­stand­ing pub­lic shares af­ter fail­ing to com­bine with a busi­ness in the sec­tor, the shell com­pa­ny said af­ter Fri­day’s clos­ing bell. The New York-based SPAC went pub­lic al­most two years ago to the day in a $200 mil­lion IPO — mean­ing its two-year timer for find­ing a busi­ness com­bi­na­tion would stop tick­ing on Ju­ly 30.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER